- Current report filing (8-K)
04 Novembre 2008 - 11:05PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) October 29, 2008
WORLD HEART CORPORATION
(Exact name of registrant as specified in
charter)
Canada
|
|
000-28882
|
|
52-2247240
|
(State or other jurisdiction of
incorporation)
|
|
(Commission
File
Number)
|
|
(IRS Employer
Identification
No.)
|
|
|
|
|
|
7799 Pardee Lane, Oakland CA
|
|
94621
|
(Address of principal executive offices)
|
|
(Zip Code)
|
(510) 563-5000
Registrants telephone number, including area
code
Not Applicable
(Former name or former address, if changed
since last report)
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
¨
Written communications pursuant to Rule 425
under the Securities Act (17 CFR 230.425)
¨
Soliciting material pursuant to Rule 14a-12
under the Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under
Exchange Act (17 CFR 240.14d-2(b))
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under
Exchange Act (17 CFR 240.13e-4(c))
Item 3.01.
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or
Standard; Transfer of Listing.
On
October 29, 2008, World Heart Corporation (the Company) received a
NASDAQ Staff Deficiency Letter indicating that the Company
does not
comply with Marketplace Rule 4310(c)(7). This rule requires the
Company to maintain a minimum of 500,000 publicly held shares for
continued listing on the NASDAQ Capital Market. For purposes of this
requirement, the number of publicly held shares excludes shares held by
affiliates, including officers, directors, or ten percent shareholders. The NASDAQ staff is reviewing the Companys
eligibility for continued listing on the NASDAQ Capital Market and had asked
the Company to provide, on or before November 21, 2008, the Companys
specific plan to achieve and sustain compliance with all the NASDAQ Capital
Market listing requirements, including the time frame for completion of the
plan. As has been previously disclosed,
the Company intends to file a registration statement to register certain shares
held by affiliates and others that were issued or are issuable in connection
with the previously announced US$30 million private placement transaction and
recapitalization. Once the shares to be
covered by the registration statement are registered, the Company expects that
sales in the open market will result in an increase in the number of publicly
held shares. The Company also intends to
submit a specific plan to achieve and sustain compliance with Marketplace Rule 4310(c)(7)
by November 21, 2008.
Item 9.01.
Financial Statements and Exhibits.
(d) Exhibits.
Exhibit 99.1
|
|
Press
Release dated November 4, 2008
|
2
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned, hereunto
duly authorized.
Date: November 4, 2008
|
|
|
|
|
|
|
|
|
|
|
WORLD HEART CORPORATION
|
|
|
|
|
By:
|
/s/ David Pellone
|
|
Name:
|
David Pellone
|
|
Title:
|
Vice President, Finance and Chief
Financial Officer
|
3
World Heart (MM) (NASDAQ:WHRTD)
Graphique Historique de l'Action
De Oct 2024 à Nov 2024
World Heart (MM) (NASDAQ:WHRTD)
Graphique Historique de l'Action
De Nov 2023 à Nov 2024